The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Male–female differences in fertility and blood pressure in ACE-deficient mice
Krege, J. H., John, S. W. M., Langenbach, L. L., Hodgin, J. B., Hagaman, J. R., Bachman, E. S., Jennette, J. C., O'Brien, D. A., & Smithies, O. (1995) · Nature · doi:10.1038/375146a0 · Cited by 644
Regulation of blood pressure by the type 1A angiotensin II receptor gene.
Ito, M., Oliverio, M. I., Mannon, P. J., Best, C. F., Maeda, N., Smithies, O., & Coffman, T. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3521 · Cited by 616
Morphology, physiology, and molecular biology of renin secretion
Hackenthal, E., Paul, M., Ganten, D., & Taugner, R. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.4.1067 · Cited by 614
Angiotensin II and Renal Fibrosis
Mezzano, S. A., Ruiz-Ortega, M., & Egido, J. (2001) · Hypertension · doi:10.1161/hy09t1.094234 · Cited by 523
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
Self-citationThe emerging role of ACE2 in physiology and disease
Hamming, I., Cooper, M., Haagmans, B., Hooper, N., Korstanje, R., Osterhaus, A., Timens, W., Turner, A., Navis, G., & van Goor, H. (2007) · The Journal of Pathology · doi:10.1002/path.2162 · Cited by 434
The angiotensin–converting enzyme gene family: genomics and pharmacology
Turner, A. J., & Hooper, N. M. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01994-5 · Cited by 406
The Cardiac Renin-Angiotensin System: Conceptual, or a Regulator of Cardiac Function?
Dostal, D. E., & Baker, K. M. (1999) · Circulation Research · doi:10.1161/01.res.85.7.643 · Cited by 398
Ferrario, C. M., Trask, A. J., & Jessup, J. A. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2005 · Cited by 385
Angiotensinogen-deficient mice with hypotension.
Tanimoto, K., Sugiyama, F., Goto, Y., Ishida, J., Takimoto, E., Yagami, K., Fukamizu, A., & Murakami, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31697-1 · Cited by 370
Role of the Renin-Angiotensin System in Vascular Diseases: Expanding the Field
Ruiz-Ortega, M., Lorenzo, O., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S., Plaza, J. J., & Egido, J. (2001) · Hypertension · doi:10.1161/hy1201.100589 · Cited by 308
Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis
Lovren, F., Pan, Y., Quan, A., Teoh, H., Wang, G., Shukla, P. C., Levitt, K. S., Oudit, G. Y., Al-Omran, M., Stewart, D. J., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00331.2008 · Cited by 307
Self-citationHuman Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., et al. (2010) · Diabetes · doi:10.2337/db09-1218 · Cited by 300
Self-citationWysocki, J., Ye, M., Rodriguez, E., González-Pacheco, F. R., Barrios, C., Evora, K., Schuster, M., Loibner, H., Brosnihan, K. B., Ferrario, C. M., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.138420 · Cited by 300
Self-citationOUDIT, G., KASSIRI, Z., PATEL, M., CHAPPELL, M., BUTANY, J., BACKX, P., TSUSHIMA, R., SCHOLEY, J., KHOKHA, R., & PENNINGER, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.007 · Cited by 245
Self-citationZhong, J., Guo, D., Chen, C. B., Wang, W., Schuster, M., Loibner, H., Penninger, J. M., Scholey, J. W., Kassiri, Z., & Oudit, G. Y. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164244 · Cited by 233
Self-citationChappell, M. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076216 · Cited by 206
Converting Enzyme Determines Plasma Clearance of Angiotensin-(1–7)
Yamada, K., Iyer, S. N., Chappell, M. C., Ganten, D., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.496 · Cited by 203
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150 · cited 1×
“This value is larger than the plasma volume, suggesting that ACE2 can reach the extravascular space [31], which is in agreement with the observations in mice described above.”
Resultde Lang, A., Osterhaus, A. D. M. E., & Haagmans, B. L. (2006) · Virology · doi:10.1016/j.virol.2006.06.011 · Cited by 134
Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice #
Österreicher, C. H., Taura, K., Minicis, S. D., Seki, E., Penz-Österreicher, M., Kodama, Y., Kluwe, J., Schuster, M., Oudit, G. Y., Penninger, J. M., et al. (2009) · Hepatology · doi:10.1002/hep.23104 · Cited by 133
Self-citationAngiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives
Iusuf, D., Henning, R. H., van Gilst, W. H., & Roks, A. J. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.090 · Cited by 131
Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue
Ahmad, S., Simmons, T. W., Varagić, J., Moniwa, N., Chappell, M. C., & Ferrario, C. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028501 · Cited by 124
Treml, B., Neu, N., Kleinsasser, A. T., Gritsch, C., Finsterwalder, T., Geiger, R., Schuster, M., Janzek, E., Loibner, H., Penninger, J. M., et al. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181c03009 · Cited by 107
Self-citationPotential role of Renin–Angiotensin-system for tumor angiogenesis in receptor negative breast cancer
Herr, D., Rodewald, M., Fraser, H. M., Hack, G., Konrad, R., Kreienberg, R., & Wulff, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.02.019 · Cited by 88
Major role for ACE-independent intrarenal ANG II formation in type II diabetes
Park, S., Bivona, B. J., Kobori, H., Seth, D. M., Chappell, M. C., Lazartigues, E. D., & Harrison‐Bernard, L. M. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00519.2009 · Cited by 87
Pathways of angiotensin‐(1–7) metabolism in the kidney
Chappell, M. C., Allred, A. J., & Ferrario, C. M. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.22 · Cited by 83
Trask, A. J., Averill, D. B., Ganten, D., Chappell, M. C., & Ferrario, C. M. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01198.2006 · Cited by 58
Baan, J., Chang, P. C., Vermeij, P., Pfaffendorf, M., & van Zwieten, P. A. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00133-2 · Cited by 38
Ruiz‐Ortega, M., Lorenzo, Ó., Rup�rez, M., Esteban, V., Mezzano, S. A., & Egido, J. (2001) · KARGER eBooks · doi:10.1159/000060153 · Cited by 37
Newby, D. E. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00171-5 · Cited by 29
Cited by
Mechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Self-citationMonteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
“Here, we report that clinical-grade human recombinant soluble ACE2 (hrsACE2), which has already been tested in phase 1 and phase 2 clinical trials (Haschke et al., 2013; Khan et al., 2017) , can reduce viral growth in Vero E6 cells by a factor of 1,000-5,000.”
Self-citationCOVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
Metadata
- Authors
- Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J., & Krähenbühl, S.
- Venue
- Clinical Pharmacokinetics
- Published
- 2013-05-17
- Volume
- 52
- Issue
- 9
- Pages
- 783-792
- ISSN
- 0312-5963 (ISSN-L)
- 1179-1926
- OpenAlex
- W2093402003
- Cited by
- 361
- References
- 35
- FWCI
- 7.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.